# MedPanel AI — First Live POC Run

**Date:** 2026-03-26
**Question:** Should I take CoQ10 at 200mg daily for my mitochondrial issues?
**Specialists:** Cardiologist, Nephrologist, Functional Medicine
**Moderator:** Synthesis agent

## Results

### Unanimous Consensus (all 3 specialists)
1. **CoQ10 200mg is SAFE** — cardiovascularly, renally, and metabolically. No concerns.
2. **CoQ10 is NOT the top priority** — lipid profile, inflammation, and kidney trajectory are all higher priority
3. **hs-CRP 5.8 needs investigation** — potential upstream driver of everything else
4. **Estradiol monitoring is a standard-of-care gap** — basic TRT monitoring that's been missed

### Key Output Quality Metrics
- Each specialist produced structured JSON with findings, perspectives, evidence citations, risk flags, cross-domain questions, and questions for the doctor
- Cross-domain flags were raised appropriately (cardiologist flagged for nephrology, functional medicine flagged for endocrinology, etc.)
- Evidence was properly tiered (strong/moderate/preliminary/mechanistic)
- Patient mode output at ~6th grade reading level
- Physician mode output with guideline references and GRADE ratings
- 7 prioritized "questions for your doctor" generated and deduplicated

### Architecture Validation
- ✅ PubMed evidence retrieval worked (API key functional)
- ✅ Specialist prompts loaded from prompts/*.md
- ✅ Agents produced structured output following the schema patterns
- ✅ Cross-domain awareness worked (specialists flagged findings for other domains)
- ✅ Moderator synthesized consensus + disagreements correctly
- ✅ Dual-mode output (patient + physician) generated
- ✅ Evidence landscape format (strong/moderate/preliminary/unknown/researching) used correctly
- ✅ Exploration framing maintained (no prescriptive language)

### What Worked
- Multi-specialist approach produced insights no single agent would have
- The cardiologist focused on lipid risk, the nephrologist on GFR trajectory, functional medicine on the inflammation-mitochondria axis — genuinely different lenses
- Cross-domain questions were specific and actionable
- The moderator correctly identified where specialists agreed and where they differed

### What to Improve
- Round 2 (cross-examination) not run in this POC — agents didn't see each other's output
- Evidence package was limited to PubMed abstracts (no Perplexity for richer evidence)
- Prompts still use some old severity vocabulary (orange/yellow vs critical/high — partially fixed)
- No cost tracking in this run
- No structured JSON validation against agent-output.json schema

